Skip to main content
$6.40 $0.10 (1.6%)

04:00 PM EDT on 07/01/22

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)

CAPS Rating: 1 out of 5

Current Price $6.40 Mkt Cap $276.6M
Open $6.28 P/E Ratio 0.00
Prev. Close $6.40 Div. (Yield) $0.00 (0.0%)
Daily Range $6.16 - $6.47 Volume 231,622
52-Wk Range $3.53 - $10.02 Avg. Daily Vol. 453,588

Caps

How do you think NASDAQ:EIGR will perform against the market?

Add Stock to CAPS Watchlist

All Players

30 Outperform
4 Underperform
 

All-Star Players

2 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EIGR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Jimbyrnes1969 (< 20)
Submitted April 09, 2015

I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock… More

Jordrok (< 20)
Submitted January 02, 2015

No revenues... yet.

Fools bullish on NASDAQ:EIGR are also bullish on:

Fools bearish on NASDAQ:EIGR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EIGR.

Recs

0
Member Avatar oscillation (75.04) Submitted: 5/28/2015 9:24:56 AM : Outperform Start Price: $32.40 NASDAQ:EIGR Score: -159.93

nev

Recs

0
Member Avatar treasureoaks (< 20) Submitted: 4/22/2015 3:54:19 PM : Outperform Start Price: $203.85 NASDAQ:EIGR Score: -177.91

Oversold.

Recs

1
Member Avatar Jimbyrnes1969 (< 20) Submitted: 4/9/2015 1:25:22 PM : Outperform Start Price: $252.36 NASDAQ:EIGR Score: -180.57

I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.

Leaderboard

Find the members with the highest scoring picks in EIGR.

Score Leader

GreenAB

GreenAB (29.90) Score: +180.05

The Score Leader is the player with the highest score across all their picks in EIGR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
GreenAB 29.90 3/20/2015 Underperform NS $405.00 -98.43% +81.62% +180.05 0 Comment
IdahoInvestor 28.07 8/17/2015 Underperform 5Y $15.75 -59.56% +82.70% +142.26 0 Comment
PAGEBOY2020 61.37 8/13/2021 Outperform 5Y $8.85 -27.98% -14.42% -13.56 0 Comment
XMFFlygal 98.75 6/10/2022 Underperform 3M $5.66 +12.54% -3.43% -15.98 0 Comment
jonboy13 91.31 11/24/2021 Underperform 5Y $6.44 -1.09% -18.57% -17.48 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. OneBee 20.36 5/4/2021 Outperform 3M $8.67 -26.53% -8.36% -18.17 0 Comment
sikiliza < 20 3/13/2020 Outperform 5Y $5.71 +11.56% +44.87% -33.31 0 Comment
foggs1 65.38 3/17/2021 Outperform 5Y $10.12 -37.06% -3.35% -33.71 0 Comment
odocoileus 44.04 9/10/2020 Outperform 5Y $10.48 -39.22% +13.85% -53.06 0 Comment
drugtrader 56.25 7/8/2020 Outperform 5Y $9.43 -32.45% +21.88% -54.33 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EIGR.